Venture Certified
| 벤처투자유형 | 2022-11-02 ~ 2025-11-01 | 20221102010039 | 2022-11-02 |
| 벤처투자유형 | 2025-11-02 ~ 2028-11-01 | 20251021010038 | 2022-11-02 |
Revenue CAGR +379.2%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 3.7B | 0.0B | 0.2B |
| Operating Profit | -8.8B | -7.6B | -4.0B |
| Net Profit | -9.7B | -8.7B | -4.0B |
| Total Assets | 57.9B | 60.0B | 16.5B |
| Total Liabilities | 23.5B | 25.9B | 6.7B |
| Total Equity | 34.4B | 34.2B | 9.8B |
Operating Loss: Op. profit -9B
3 Consecutive Years of Net Loss
▲ 4063.1%
▼ 50.2%
▲ 99.0%
▼ 5.2%
▲ 14.4%
| Name | Position | Role |
|---|---|---|
| 김태언,김일기 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "충청북도 충주시",
"ceo_name": "김태언,김일기",
"certificate": [
{
"cert_number": "20221102010039",
"changes": "",
"disclosure_date": "2022-11-02",
"first_cert_date": "2022-11-02",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2022-11-02 ~ 2025-11-01"
},
{
"cert_number": "20251021010038",
"changes": "",
"disclosure_date": "2025-10-21",
"first_cert_date": "2022-11-02",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2025-11-02 ~ 2028-11-01"
}
],
"company_name": "포리바이오 주식회사",
"corp_no": "154511-*******",
"financials": {
"2022": {
"capital_stock": 556190000,
"cost_of_sales": 48617000,
"current_assets": 708283000,
"current_liabilities": 38044000,
"gross_profit": -32367000,
"net_income": -400211000,
"net_income_bs": -400211000,
"non_current_assets": 940280000,
"non_current_liabilities": 630000000,
"non_operating_expenses": 5281000,
"non_operating_income": 7218000,
"operating_profit": -402148000,
"revenue": 16250000,
"sga_expenses": 369781000,
"total_assets": 1648563000,
"total_equity": 980519000,
"total_liabilities": 668044000
},
"2023": {
"capital_stock": 671120000,
"cost_of_sales": 10200000,
"current_assets": 2729560000,
"current_liabilities": 1246387000,
"gross_profit": -8523000,
"net_income": -865530000,
"net_income_bs": -865551000,
"non_current_assets": 3274779000,
"non_current_liabilities": 1339471000,
"non_operating_expenses": 114289000,
"non_operating_income": 12708000,
"operating_profit": -763949000,
"revenue": 1677000,
"sga_expenses": 755426000,
"total_assets": 6004339000,
"total_equity": 3418481000,
"total_liabilities": 2585858000
},
"2024": {
"capital_stock": 705884000,
"cost_of_sales": 400904000,
"current_assets": 1955097000,
"current_liabilities": 1649173000,
"gross_profit": -27746000,
"net_income": -974610000,
"net_income_bs": -974610000,
"non_current_assets": 3835578000,
"non_current_liabilities": 698324000,
"non_operating_expenses": 103983000,
"non_operating_income": 4821000,
"operating_profit": -875448000,
"revenue": 373158000,
"sga_expenses": 847702000,
"total_assets": 5790675000,
"total_equity": 3443178000,
"total_liabilities": 2347497000
}
},
"industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
"investment": [
{
"amount": "102,000,000",
"changes": "102,000,000",
"date": "2022-09-07"
},
{
"amount": "476,077,384",
"changes": "476,077,384",
"date": "2022-08-12"
}
],
"main_products": "PDRN, PN",
"phone": "043-750-****",
"years": [
2024,
2023,
2022
]
}